PMID: 11899922Mar 20, 2002Paper

A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands)

Cancer Causes & Control : CCC
Maurice P A ZeegersPiet A van den Brandt

Abstract

In a prospective cohort study among 120,852 adult subjects the authors investigated the associations between cigarette, cigar, pipe, environmental tobacco smoking (ETS), and bladder cancer. In 1986 all subjects completed a questionnaire on cancer risk factors. Follow-up for incident bladder cancer was established by linkage to cancer registries until 1992. The case-cohort analysis was based on 619 cases and 3346 subcohort members. Compared with lifelong non-smokers the age- and sex-adjusted incidence rate ratios (RR) for ex- and current cigarette smokers were 2.1 (95% CI 1.5-3.0) and 3.3 (95% CI 2.4-4.6), respectively. The RR for smoking duration was 1.03 (95% CI: 1.02-1.04) per 1-year increment. The RR per 10 cigarettes/day was 1.3 (95% CI 1.2-1.4). Tar and nicotine exposure increased bladder cancer risk only weakly. It appeared that associations of cigarette smoking characteristics with bladder cancer risk were largely attributable to cigarette smoking duration only. Smoking cessation, age at first exposure, filter-tip usage, cigar and pipe smoking, and ETS were no longer associated with bladder cancer risk after adjustment for frequency and duration of smoking. The authors conclude that current cigarette smokers have a three...Continue Reading

Citations

Oct 13, 2006·Current Opinion in Gastroenterology·Alexander SchneiderDavid C Whitcomb
Apr 28, 2007·Der Urologe. Ausg. A·J E Altwein
May 14, 2008·Laboratory Investigation; a Journal of Technical Methods and Pathology·James M Crawford
Nov 18, 2009·Journal of the National Cancer Institute·Dalsu BarisDebra T Silverman
Dec 10, 2013·Journal of the Chinese Medical Association : JCMA·Zhon-Min HuangGuang-Dar Juang
Mar 24, 2016·European Journal of Epidemiology·Abdulmohsen H Al-ZalabaniMaurice P Zeegers
Mar 23, 2018·International Journal of Environmental Research and Public Health·Frits H M van OschMaurice P Zeegers
Oct 13, 2006·Environmental Health Perspectives·Maurice P ZeegersPiet A van den Brandt
Aug 9, 2006·International Journal of Cancer. Journal International Du Cancer·Bine Kjøller BjerregaardElio Riboli
Jul 11, 2007·Journal of Cancer Research and Clinical Oncology·Yuan-Hung WangHung-Yi Chiou
Aug 19, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joaquim BellmuntHans von der Maase
Jun 11, 2011·Cancer Causes & Control : CCC·Charlotte S Wilhelm-BenartziCarmen J Marsit
Aug 13, 2013·Archives of Environmental & Occupational Health·Sania AmrChristopher A Loffredo
Jun 18, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Weiwei WangChunbin Wang
May 21, 2019·International Journal of Cancer. Journal International Du Cancer·Maarit A LaaksonenClaire M Vajdic
Mar 4, 2006·Der Urologe. Ausg. A·K GolkaP J Goebell
Jul 9, 2005·International Journal of Cancer. Journal International Du Cancer·Tania CarreónGrace K LeMasters
Jan 6, 2009·International Journal of Urology : Official Journal of the Japanese Urological Association·Yuan-Hung WangHung-Yi Chiou
May 2, 2008·Toxicological Sciences : an Official Journal of the Society of Toxicology·Rong-Jane ChenYing-Jan Wang
Dec 5, 2008·Scandinavian Journal of Urology and Nephrology. Supplementum·Paolo Boffetta
Dec 14, 2007·The Journal of Urology·Alan M NiederDavid J Lee
Jun 24, 2008·Journal of Toxicology and Environmental Health. Part a·Klaus GolkaSilvia Selinski
Feb 24, 2015·Virchows Archiv : an International Journal of Pathology·Eva CompératChristian Pfister
Jun 1, 2013·Arab Journal of Urology·Abdou K ChamssuddinLoauy Alia
Jul 6, 2013·Current Opinion in Nephrology and Hypertension·Yair LotanIvan Tack
Apr 22, 2016·International Journal of Epidemiology·Frits Hm van OschMaurice P Zeegers
Sep 27, 2005·Cancer Causes & Control : CCC·Margaret E WrightDemetrius Albanes
Feb 6, 2008·International Urology and Nephrology·Fuat DemirelUgur Altug
Jul 7, 2017·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Frits H M van OschMaurice P Zeegers
May 20, 2009·The Journal of Urology·Alan M NiederDavid J Lee
Sep 15, 2009·British Journal of Community Nursing·Beverley Anderson
May 29, 2007·World Journal of Urology·Cristiane Murta-NascimentoNúria Malats
May 3, 2019·Cancer Prevention Research·Yueyao LiJuhua Luo
Apr 2, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Mieke J J Van HemelrijckZubair Kabir
May 27, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Mirjam M HeinenPiet A van den Brandt
Nov 9, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Li TaoJian-Min Yuan
Dec 8, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Yun-Ling ZhengChristopher A Loffredo
Oct 4, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Maria C MirGrant Izmirlian
May 18, 2004·Cancer Treatment Reviews·John D ChesterAndrew S Protheroe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.